Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Minor: Specified Drug-use Survey of Leqvio for s.c. Injection Trial completed
- Minor: Probiotic Supplementation on Stress and Anxiety in Students Trial completed
- Minor: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial Enrollment closed, study ongoing
- Minor: Gastrointestinal Discomfort and Infections in Healthy Term Infants Trial completed
- Minor: Specified Drug-use Surveillance of Fabhalta Capsules Trial completed
- Minor: New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors Enrollment closed, study ongoing
- Minor: 9-Valent Human Papillomavirus Recombinant Vaccine · Idiopathic CD4 T Cell Lymphocytopenia Trial completed
- Minor: Emicizumab · Type 3 Von Willebrand Disease Primary completion pushed from Apr 30, 2027 to Oct 6, 2027
- Minor: Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Locally Advanced Rectal Cancer Primary completion pushed from Dec 12, 2029 to Mar 13, 2030
- Minor: IBDminds - Mapping the Influence of aNxiety and DepreSsion on IBD Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Minor: Proximal Versus Distal Superior Cluneal Nerve Block in Entrapment Neuropathy Trial completed
- Minor: Mosunetuzumab · Systemic Lupus Erythematosus With or Without Active Lupus Nephritis Primary completion pushed from Feb 28, 2028 to Aug 11, 2028
- Minor: Bioavailability of Phlorotannins and Carotenoids Following the Intake of Crackers Fortified With Seaweed Trial completed
- Minor: Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses Sponsor refiled this as active, not recruiting (was completed)
- Minor: Dexmedetomidinine · Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery Trial completed
- Minor: Dexmedetomidine in Postoperative Analgesia Trial status changed: Enrolling by Invitation → Completed
- Minor: Nuwiq for Perioperative Management · Haemophilia A on Emicizumab Regular Prophylaxis Study Primary and study completion dates pushed to Dec 2026
- Minor: Pre-Emptive Parecoxib Sodium for Pain Control During CT-Guided Lung Nodule Localization Enrollment closed, study ongoing
- Minor: ACTEMRA® · Pediatric Adamantinomatous Craniopharyngioma Enrollment closed, study ongoing
- Minor: Ferric Citrate and Chronic Kidney Disease in Children Enrollment closed, study ongoing
- Minor: OSE2101 Alone or in Combination With Pembrolizumab vs BSC · Platinum-sensitive Recurrent OC Trial completed
- Minor: Post-operative Analgesic Effect of Oral Nefopam Enrollment closed, study ongoing
- Minor: Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM) Trial completed
- Minor: Herbal Supplement (Biocidin REMOVE) for Bacterial Overgrowth in Irritable Bowel Syndrome Trial status changed: Enrolling by Invitation → Recruiting
- Minor: Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion Enrollment closed, study ongoing
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates